|82 Devonshire St , Boston, MA 02109|
|Fund Manager||Brett Sumsion|
|Manager Tenure||4 Years 4 Months|
The fund seeks high total return with a secondary objective of principal preservation as the fund approaches its target date and beyond. Investing primarily in a combination of FidelityÂ® domestic equity funds,international equity funds,bond funds,and short-term funds (underlying FidelityÂ® funds).Allocating assets according to a neutral asset allocation strategy shown in the glide path below that adjusts over time until itreaches an allocation similar to that of the Fidelity Advisor FreedomÂ® Income Fund,approximately 10 to 19 years after theyear 2030.Fidelity Management & Research Company LLC (the Adviser) may modify the fundâ€™s neutral asset allocationsfrom time to time when in the interests of shareholders.Buying and selling futures contracts (both long and short positions) in an effort to manage cash flows efficiently, remain fully invested,or facilitate asset allocation.The neutral asset allocation shown in the glide path depicts the allocation to domestic equity funds,international equity funds,bond funds (including investment grade debt,inflation-protected debt,and long-term treasury debt),and short-term funds.The Adviser,under normal market conditions, will make investments that are consistent with seeking high total return forseveral years beyond the fund's target retirement date in an effort to achieve the fund's overall investment objective.
|Asset Type||% Of Allocation|
|Total Net Assets||5.15 B|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 09/30/2021||Average Annual Current Performance Quarterly As Of 09/30/2021||Avg Annual Current Performance Monthly As Of 09/30/2021||Avg Annual Current Performance Quarterly As Of 09/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|FSIPX||FIDELITY SER INFL PR BOND ID||5.65%|
|FDMLX||FIDELITY SER INTRINSIC OPP FD||5.50%|
|FCGSX||FIDELITY SER GROWTH COMPANY F||5.32%|
|FIGSX||FIDELITY SER INTL GROWTH FD||4.99%|
|FSOSX||FIDELITY SER OVERSEAS FUND||4.98%|
|FINVX||FIDELITY SER INTL VALUE FD||4.97%|
|FGLGX||FIDELITY SER GROWTH & INCOME||4.79%|
|FBLEX||FIDELITY SER ST SEL LG CP VAL||4.06%|
|FNKLX||FIDELITY SER VALUE DISCOVERY||3.12%|
|FSIGX||FIDELITY SERIES INV GRADE BD||21.01%|
Master The Market with the Help of Our Financial Experts
Stocks moving in premarket trading include Procter & Gamble. Ulta, Netflix, Johnson & Johnson and Teladoc.
Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.
Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.
Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.
Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.
Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.
Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.
Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.
Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.